Ott G et al. |
Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59. |
1995 |
Vaccine |
pmid:8578842
|
Higgins DA et al. |
MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice. |
1996 |
Vaccine |
pmid:8782343
|
Singh M et al. |
A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2. |
1998 |
Vaccine |
pmid:9795387
|
Minutello M et al. |
Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons. |
1999 |
Vaccine |
pmid:9987141
|
Hilgers LA et al. |
Sulfolipo-cyclodextrin in squalane-in-water as a novel and safe vaccine adjuvant. |
1999 |
Vaccine |
pmid:9987157
|
Podda A |
The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine. |
2001 |
Vaccine |
pmid:11257408
|
Iorio AM et al. |
Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. |
2003 |
Vaccine |
pmid:12922092
|
Madhun AS et al. |
An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. |
2010 |
Vaccine |
pmid:21034828
|
Garcia-Sicilia J et al. |
Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents. |
2011 |
Vaccine |
pmid:21504774
|
Javelle E et al. |
Delayed focal lipoatrophy after AS03-adjuvanted influenza A (H1N1) 2009 vaccine. |
2011 |
Vaccine |
pmid:21172376
|
Esposito S et al. |
Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents. |
2011 |
Vaccine |
pmid:21199699
|
Esposito S et al. |
Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major. |
2010 |
Vaccine |
pmid:20888873
|
Pellegrini M et al. |
MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. |
2009 |
Vaccine |
pmid:19751689
|
Forrest HL et al. |
Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets. |
2009 |
Vaccine |
pmid:19406182
|
Camilloni B et al. |
Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages. |
2009 |
Vaccine |
pmid:19410623
|
Phillips CJ et al. |
Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness. |
2009 |
Vaccine |
pmid:19379786
|
Ansaldi F et al. |
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates. |
2010 |
Vaccine |
pmid:20433807
|
Carmona A et al. |
Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months. |
2010 |
Vaccine |
pmid:20600478
|
Camilloni B et al. |
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. |
2010 |
Vaccine |
pmid:20846530
|
Fabbiani M et al. |
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients. |
2011 |
Vaccine |
pmid:21349364
|
Dell'Era L et al. |
Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis. |
2012 |
Vaccine |
pmid:22138210
|
Brito LA et al. |
An alternative renewable source of squalene for use in emulsion adjuvants. |
2011 |
Vaccine |
pmid:21723355
|
Puig-Barberà J et al. |
Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. |
2007 |
Vaccine |
pmid:17889411
|
Guillon C et al. |
Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits. |
2007 |
Vaccine |
pmid:17904700
|
Wack A et al. |
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice. |
2008 |
Vaccine |
pmid:18162266
|
O'Hagan DT et al. |
Cationic microparticles are a potent delivery system for a HCV DNA vaccine. |
2004 |
Vaccine |
pmid:15542189
|
O'Hagan DT et al. |
The mechanism of action of MF59 - an innately attractive adjuvant formulation. |
2012 |
Vaccine |
pmid:22682289
|
Yu S et al. |
Novel Th1-biased adjuvant, SPO1, enhances mucosal and systemic immunogenicity of vaccines administered intranasally in mice. |
2012 |
Vaccine |
pmid:22709954
|
Dey AK et al. |
Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein. |
2012 |
Vaccine |
pmid:22366638
|
Chandramouli S et al. |
Generation of a parvovirus B19 vaccine candidate. |
2013 |
Vaccine |
pmid:23827313
|
Yang WH et al. |
Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: an observer-blind, randomized trial. |
2013 |
Vaccine |
pmid:23856331
|
Nielsen AB et al. |
Immune response after one or two doses of pandemic influenza A (H1N1) monovalent, AS03-adjuvanted vaccine in HIV infected adults. |
2012 |
Vaccine |
pmid:23036498
|
Rouleau I et al. |
Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine. |
2013 |
Vaccine |
pmid:24144473
|
Vinay TN et al. |
Toxicity and dose determination of quillaja saponin, aluminum hydroxide and squalene in olive flounder (Paralichthys olivaceus). |
2014 |
Vet. Immunol. Immunopathol. |
pmid:23570990
|
Drulak MW et al. |
Vaccination of seropositive subjects with CHIRON CMV gB subunit vaccine combined with MF59 adjuvant for production of CMV immune globulin. |
2000 |
Viral Immunol. |
pmid:10733168
|
Marshall BC and Adler SP |
Avidity maturation following immunization with two human cytomegalovirus (CMV) vaccines: a live attenuated vaccine (Towne) and a recombinant glycoprotein vaccine (gB/MF59). |
2003 |
Viral Immunol. |
pmid:14733736
|
Heinemann L et al. |
Effective induction of type 1 helper IgG2a and cytotoxic T-cell responses in mice following immunization with human papillomavirus type 16 E2 in MF59. |
2008 |
Viral Immunol. |
pmid:18476769
|
Burke B et al. |
Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits. |
2009 |
Virology |
pmid:19249806
|
Stephenson I et al. |
Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine. |
2004 |
Virus Res. |
pmid:15163495
|
Clouse SD |
Brassinosteroids. Plant counterparts to animal steroid hormones? |
2002 |
Vitam. Horm. |
pmid:12481548
|
Zadák Z et al. |
[The role of cholesterol and intermediary metabolites of its synthesis in intensive care and parenteral nutrition]. |
2000 |
Vnitr Lek |
pmid:15637893
|
PokrovskiÄ AA et al. |
[Method of isolating, identifying and quantitatively determining alkanes, cycloalkanes, monocyclic arenes and squalene in animal organs and tissues]. |
1978 Sep-Oct |
Vopr Pitan |
pmid:716335
|
Markelova VF and Levachev MM |
[Inclusion of C14-acetate in cholesterol and tissue squalene of rats in choline-protein deficiency]. |
1967 Nov-Dec |
Vopr Pitan |
pmid:5610866
|
Gonor KV et al. |
[The influence of a diet with including amaranth oil on antioxidant and immune status in patients with ischemic heart disease and hyperlipoproteidemia]. |
2006 |
Vopr Pitan |
pmid:17313043
|
Gonor KV et al. |
[The influence of diet with including amaranth oil on lipid metabolism in patients with ischemic heart disease and hyperlipoproteidemia]. |
2006 |
Vopr Pitan |
pmid:16862949
|
Kulakova SN et al. |
[Amaranths oil: peculiarities of chemical composition and influence on lipid metabolism by rats]. |
2006 |
Vopr Pitan |
pmid:16862953
|
Palamarchuk VI et al. |
[Content of squalene and sterols in tissues of the hemopoietic system in normal rats and in experimental leukemia]. |
1983 May-Jun |
Vopr. Med. Khim. |
pmid:6880121
|
Kozlov VG and Viktorova EG |
[Evaluation of the efficiency and reactogenicity of emulsion-based adjuvant systems in the manufacture of polyclonal enteroviral diagnostic sera]. |
2011 Mar-Apr |
Vopr. Virusol. |
pmid:21545042
|
Zhao M et al. |
[Research progress on the squalene synthase]. |
2003 |
Wei Sheng Wu Xue Bao |
pmid:16281569
|
Lynen F |
[The biochemical basis of the biosynthesis of cholesterol and fatty acids]. |
1966 |
Wien. Klin. Wochenschr. |
pmid:4296920
|
Bakalar B et al. |
Changes in cholesterol and its precursors during the first days after major trauma. |
2003 |
Wien. Klin. Wochenschr. |
pmid:14743581
|
|
Global Advisory Committee on Vaccine Safety, 6-7 June 2006. |
2006 |
Wkly. Epidemiol. Rec. |
pmid:16841398
|
Richter E et al. |
Stimulation of the faecal excretion of 2,4,5,2',4',5'-hexachlorobiphenyl in rats by squalane. |
1983 |
Xenobiotica |
pmid:6415933
|
Hu JJ et al. |
[Antibody production and its neutralization of Abeta42's cytoxicity in BALB/c mice induced by Abeta42 and its subunit vaccines]. |
2004 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:15191720
|
Ikekawa T et al. |
[Studies on antitumor activity of squalene and its related compounds]. |
1986 |
Yakugaku Zasshi |
pmid:3772729
|
Tsai TF |
MF59 adjuvanted seasonal and pandemic influenza vaccines. |
2011 |
Yakugaku Zasshi |
pmid:22129867
|
Abe I |
[Engineering of squalene cyclizing enzymes]. |
2008 |
Yakugaku Zasshi |
pmid:18670176
|
Zhang Y et al. |
[Chemical constituents from the mangrove plant Ceriops tagal]. |
2005 |
Yao Xue Xue Bao |
pmid:16408813
|
Sondergaard E et al. |
Alimentary production of gallstones in hamsters. 28. Influence of isomerized squalene on gallstone production. |
1974 |
Z Ernahrungswiss |
pmid:4450595
|
Dam H et al. |
Alimentary production of gallstones in hamsters. 27. Influence of supplementation of the gallstone producing diet with squalene, cholesterol, certain other sterols, fish oil fatty acid ethyl esters, and modification of the basal diet on gallstone production and levels of cholesterol in serum and liver. |
1974 |
Z Ernahrungswiss |
pmid:4615449
|
Kipping D |
[Observations on skin surface fats]. |
1965 |
Z Haut Geschlechtskr |
pmid:5860995
|
Gloor M |
[The significance of physiological and biochemical deviations from the norm on the skin surface for infectious skin diseases (proceedings)]. |
1976 |
Z. Hautkr. |
pmid:13544
|
de la Puerta R et al. |
Effect of minor components of virgin olive oil on topical antiinflammatory assays. |
2000 Sep-Oct |
Z. Naturforsch., C, J. Biosci. |
pmid:11098836
|
Kopena R et al. |
Lipophilic compounds from the femoral gland secretions of male Hungarian green lizards, Lacerta viridis. |
2009 May-Jun |
Z. Naturforsch., C, J. Biosci. |
pmid:19678551
|
Liu Y et al. |
[Researches on influence of squalene synthase gene polymorphism on catalytic efficiency of its encode enzyme in Glycyrrhiza uralensis]. |
2012 |
Zhongguo Zhong Yao Za Zhi |
pmid:23627178
|
Li RC et al. |
[Study on the safety and immunogenicity of MF59-adjuvanted influenza subunit vaccine in Chinese elderly]. |
2008 |
Zhonghua Liu Xing Bing Xue Za Zhi |
pmid:19040034
|